Efficacy and safety of anti-obesity drugs in metabolic dysfunction-associated steatotic liver disease: An updated review
Marcio José Concepción‐Zavaleta(Universidad Científica del Sur), José Paz‐Ibarra(National University of San Marcos), Jhean Gabriel Gonzáles Yovera(Hospital Base Guillermo Almenara Irigoyen), Juan Eduardo Quiroz‐Aldave(Ten Chen Hospital), Gemma Y Ruvalcaba-Barbosa(Autonomous University of San Luis Potosí), Leonardo D Cura-Rodríguez(Autonomous University of San Luis Potosí), Jenyfer María Fuentes‐Mendoza(Universidad Científica del Sur), Aranza I Pérez-Reyes(Autonomous University of San Luis Potosí), Luis Alberto Concepción‐Urteaga(Regional Medical Center)
Cited by 3
Related Papers
Thyroid dysfunction and female infertility. A comprehensive review
|Diabetes & Metabolic Syndrome Clinical Research & Reviews|2023|32
Thyrotoxic Cardiomyopathy: State of the Art
|touchREVIEWS in Endocrinology|2023|30
From liver to hormones: The endocrine consequences of cirrhosis
|World Journal of Gastroenterology|2024|26
Diabetic neuropathy: Past, present, and future.
|PubMed|2023|22
Endocrine factors associated with infertility in women: an updated review
|Expert Review of Endocrinology & Metabolism|2023|20